Abstract
The aim of this work was to investigate the impact of single amino acid substitutions occurring in specific porin OprD on carbapenem resistance of cystic fibrosis (CF) strains of Pseudomonas aeruginosa. A PAO1ΔoprD mutant was complemented with the oprD genes from five carbapenem-resistant CF strains exhibiting very low amounts of mutated OprD porins in their outer membrane despite wild-type levels of oprD transcripts. Compared with wild-type porin from strain PAO1, single amino acid substitutions S403P (in periplasmic loop 8), Y242H, S278P and L345P (in β-sheets 10, 12 and 14, respectively) were found to result in reduced amounts of OprD in the outer membrane, increased carbapenem resistance, and slower growth in minimal medium containing gluconate, an OprD substrate, as the sole source of carbon and energy. This indicates that in CF strains of P. aeruginosa, loss of porin OprD may not only result from mutations downregulating the expression of or disrupting the oprD gene, but also from mutations generating deleterious amino acid substitutions in the porin structure.
References
Dec 3, 1999·Science·S WicknerS Gottesman
Dec 28, 1999·Plasmid·T T HoangH P Schweizer
May 20, 2000·Science·A OliverJ Blázquez
Jun 20, 2001·Journal of Microbiological Methods·S F EppM Kok
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Oct 24, 2007·Nature Structural & Molecular Biology·Shyamasri BiswasBert van den Berg
Jul 1, 2009·Microbiology and Immunology·Yumiko SanbongiNaomasa Gotoh
Oct 14, 2009·Clinical Microbiology Reviews·Philip D ListerNancy D Hanson
Dec 7, 2010·International Journal of Antimicrobial Agents·Timothy R Walsh
Dec 15, 2010·Antimicrobial Agents and Chemotherapy·Cédric MullerKaty Jeannot
Dec 8, 2011·MBio·Hanh H HoangStephen Lory
Apr 17, 2013·The Journal of Antimicrobial Chemotherapy·Damien FournierKaty Jeannot
Citations
Feb 6, 2017·ACS Infectious Diseases·Ramkumar IyerAlita A Miller
Aug 8, 2015·Antimicrobial Agents and Chemotherapy·M BerrazegP Plésiat
Nov 2, 2017·MBio·Peter JorthStephen J Salipante
Sep 9, 2020·Molecular Microbiology·Nicolas Oswaldo GomezRomé Voulhoux
Feb 6, 2018·FEMS Microbiology Letters·Shawn T ClarkDavid M Hwang
May 24, 2017·The Journal of Antimicrobial Chemotherapy·Jwu-Ching ShuTsu-Lan Wu
Apr 24, 2018·Frontiers in Microbiology·Carla López-CausapéAntonio Oliver
Aug 2, 2017·Journal of Medical Microbiology·Theodoros KarampatakisEmmanuel Roilides
Nov 14, 2019·MBio·Andreu Coello PelegrinJuliëtte A Severin
Oct 6, 2017·FEMS Microbiology Reviews·Sylvie ChevalierPierre Cornelis
Sep 15, 2020·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Shyam Sunder Tummanapalli, Mark Dp Willcox
Nov 17, 2020·Frontiers in Microbiology·Candace M MarrThomas A Russo
Feb 20, 2020·Antimicrobial Agents and Chemotherapy·C A ColqueA M Smania
May 4, 2021·Frontiers in Cellular and Infection Microbiology·R Frèdi LangendonkJoanne L Fothergill
Aug 28, 2021·International Journal of Molecular Sciences·Petra PusicUdo Bläsi